Wave Life Sciences Announces Continued Momentum in GSK Colla

GSK has selected the first two programs to advance following achievement of target validation, marking transition to next phase of research collaboration; programs utilize Wave’s next generation...

Related Keywords

United States , Cambridge , Cambridgeshire , United Kingdom , Alicia Suter , Paul Bolno , Kate Rausch , Jack Godfrey , Christopher Acker , Pachamuthu Kandasamy , Wei Liu , Exchange Commission , Wave Life Sciences Ltd , Linkedin , Upcoming Congress Presentations , Twitter , Wave Life Sciences , Wave Life Sciences Nasdaq , Nasdaq , Life Sciences , Chief Executive Officer , Wave Life , Annual Meeting , Extrahepatic Tissues Using , Novel Phosphoryl Guanidine Backbone Variants , Senior Scientist , Abstract Session , Oligonucleotide Therapeutics , Oligonucleotides That Support Targeted , Non Human Primates , Epigenetic Editing , Phosphoryl Guanidine , Extrahepatic Tissues , Vice President Medicinal Chemistry , Sequence Versatility , Through Oligonucleotide Chemical Modifications , Private Securities Litigation Reform Act , Annual Report , Markets ,